Editorial: Neurocardiology: the science of heart–brain interactions

• by Shubham Tomar, Karita Claudia Freitas Lidani, Ravinder Mallugari, Katherine Longardner, Bhavya Jaya Venugopal

• July 21, 2026

Oral Aleniglipron Reduced Weight at 36 Weeks

In a phase 2b trial, the highest dose produced an estimated 12% mean weight reduction vs 1% with placebo, although gastrointestinal adverse events were common.

• by Kathryn Wighton

• July 16, 2026

• 6 min

Pilot Study Assesses AI-Guided Cardiac Ultrasound

Researchers examined image acquisition, interpretation agreement, and clinical management decisions among advanced practice providers.

• by Kathryn Wighton

• June 26, 2026

• 4 min

Pregnancy Health Score Tied to Later Cardiometabolic Risk

A modified cardiovascular health score during pregnancy was associated with later diagnosis of chronic hypertensive and metabolic conditions.

• by Andrea Surnit

• June 29, 2026

• 4 min